scispace - formally typeset
Y

Yutaka Shimada

Researcher at University of Toyama

Publications -  445
Citations -  15929

Yutaka Shimada is an academic researcher from University of Toyama. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 58, co-authored 441 publications receiving 14980 citations. Previous affiliations of Yutaka Shimada include Kyoto University & Niigata University.

Papers
More filters
Journal ArticleDOI

A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray

TL;DR: LAGE-1 might have the potential to be a target antigen for anti-tumoral immunotherapy in esophageal cancers because of its tumor-specific expression similar to that of MAGE-A1.
Journal ArticleDOI

Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia-Inducible Factor-1α in the Remnant Kidney Model

TL;DR: Oral administration of hachimijiogan for seven days suppressed urinary protein excretion and urinary 8-OHdG, a marker of antioxidant activity, equally as well as oral administration of candesartan cilexetil.
Journal ArticleDOI

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.

TL;DR: It is suggested that IL-15 induces the effector functions of resting NK cells throughout the body, and thereby plays a critical role in the activation of tissue-associated immune responses.
Journal ArticleDOI

Reduction of perception of chronic fatigue in an observational study of patients receiving 12 weeks of Kampo therapy.

TL;DR: A reduction of the perception of chronic fatigue was observed in patients receiving 12 weeks of Kampo therapy, and the mental fatigue, physical fatigue, and sleep scores of both groups and the work score of CFG, were decreased.
Journal ArticleDOI

Relationship of the ipsilateral rotation in night period and striatal dopamine content reduction in unilateral nigrostriatal 6-OHDA lesioned rats

TL;DR: The results suggested that the evaluation of ipsilateral rotation, taken the level of 95% rotation to the lesioned side as a standard, was able to discriminate well-lesioned rats without apomorphine treatment after unilateral nigrostriatal 6-OHDA application.